Abstract:Hepatocellular carcinoma (HCC) remains a major cause of cancer-related death worldwide. Metallothioneins (MTs) are low-molecular weight, cysteine-rich proteins, and classified into multiple classes. One of the MT species, MT1H, is down regulated in HCC. However, the roles of MT1H in HCC are not fully understood. The expression of MT1H in large datasets derived from TCGA databases. Hepatoma HepG2 and Hep3B cells were transfected with full length Flag-tagged MT1H. The cell growth curved was obtained through MTT assay. Invasiveness and migration ability of hepatoma cells was studied through the matrigel-coated transwell assay. HepG2-Vector and HepG2-MT1H cells were subcutaneously injected into nude mice for assessing in vivo tumorigenicity of MT1H over-expression. The results from TCGA RNASeq2 data showed that MT1H is significantly down regulated in most HCC analyzed. MT1H expression level was found to be markedly decreased in all HCC tumors. Hepatoma HepG2 and Hep3B cells were transfected with full length Flag-tagged MT1H. Enforced expression of MT1H in HepG2 and Hep3B cells led to a more than 50% decrease in colony numbers as compared with control cells. The DNA synthesis capability was significantly decreased in MT1H-overexpressed hepatoma cells. Ectopic overexpression of MT1H significantly impaired the migration capability of hepatoma cells. We found that Wnt/&bgr;-catenin pathway related genes were significantly enriched in the HCC patients with low MT1H expression. Consistently, ectopic over-expression of MT1H in HCC cells significantly suppressed the mRNA level of &bgr;-catenin signaling downstream targets (c-Myc, MMP7, LEF1, and TCF4) . As expected, Wnt/&bgr;-catenin nuclear translocation was significantly attenuated in MT1H over-expressed HCC cells. To assess the effect of MT1H over-expression on tumorigenicity in vivo, we subcutaneously injected nude mice with HepG2-Vector and HepG2-MT1H cells. The tumors formed by HepG2-MT1H cells were significantly smaller than that of control cells. The average tumor weight of the MT1H- transfected cells inoculated mice was significantly decreased at day 30. Our findings suggest that MT1H functions as tumor suppressor in HCC mediated by Wnt/&bgr;-catenin signaling pathway.

Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions

Low Metallothionein 1M (MT1M) is Associated with Thyroid Cancer Cell Lines Progression.

Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients

Metallothionein 1g Functions As A Tumor Suppressor in Thyroid Cancer Through Modulating the Pi3k/Akt Signaling Pathway

Metallothionein gene expression is altered in oral cancer and may predict metastasis and patient outcomes

Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival

The roles of metallothioneins in carcinogenesis

Metallothionein 1h Functions As A Tumor Suppressor in Hepatocellular Carcinoma

Metallothionein Expression in Hepatocellular Carcinoma.

Metallothionein 1H (MT1H) Functions As a Tumor Suppressor in Hepatocellular Carcinoma Through Regulating Wnt/β-catenin Signaling Pathway

Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer

Metallothionein polymorphisms in pathological processes

Clinicopathological Significance of Altered Metallothionein 2A Expression in Gastric Cancer According to Lauren's Classification.

Expression and Prognostic Significance of Metallothionein in Non-small Cell Lung Cancer

A case-control study of Metallothionein-1 expression in breast cancer and breast fibroadenoma

[Metallothionein and Its Isoform Genes Expression in the Human Pancreatic Cancer Cell Strains and Their Function].

Metallothionein 1h Tumour Suppressor Activity in Prostate Cancer is Mediated by Euchromatin Methyltransferase 1

Metallothionein 1 Family Profiling Identifies MT1X As a Tumor Suppressor Involved in the Progression and Metastastatic Capacity of Hepatocellular Carcinoma.

Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas

Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.